PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1904726
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1904726
According to Stratistics MRC, the Global Pet Orthopedic Implants & Prosthetics Market is accounted for $0.48 billion in 2025 and is expected to reach $0.82 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Pet Orthopedic Implants & Prosthetics are specialized medical devices designed to restore mobility, function, and quality of life in animals with musculoskeletal injuries or congenital deformities. These devices include plates, screws, pins, joint replacements, and custom prosthetic limbs that support bone healing, joint stabilization, and limb replacement. Widely used in veterinary surgery, they address fractures, ligament injuries, hip or knee dysplasia, and amputations, enabling pets to regain natural movement. Advanced materials and precise engineering ensure durability, biocompatibility, and comfort, while innovations in prosthetics allow for customized solutions tailored to the size, anatomy, and activity level of each animal.
Growing Pet Ownership & Humanization
The rising trend of pet ownership globally, combined with the humanization of pets, is driving demand for advanced orthopedic care. Pet owners increasingly seek treatments that enhance their animals' quality of life, similar to human healthcare. As pets are considered family members, there is a higher willingness to invest in surgeries, implants, and prosthetics to restore mobility and functionality. This emotional and financial commitment fuels market expansion, encouraging veterinary providers to adopt cutting-edge orthopedic solutions. Thus, it drives market expansion.
High Treatment & Device Costs
Despite growing demand, the high cost of pet orthopedic implants and prosthetics remains a significant barrier. Advanced materials, precision engineering, and customization elevate device prices, making treatments unaffordable for many pet owners. Additionally, specialized veterinary procedures require expert surgeons and post-operative care, further increasing overall expenditure. This financial burden limits market penetration, particularly in emerging regions, and slows adoption of innovative solutions, challenging manufacturers to balance affordability with quality and technological advancement.
Increased Veterinary Infrastructure
Expanding veterinary infrastructure worldwide presents a strong growth opportunity for the market. The proliferation of specialized clinics, surgical centers, and rehabilitation facilities enables wider access to orthopedic treatments and prosthetic solutions. Investment in modern diagnostic tools, imaging technologies, and skilled veterinary professionals enhances service delivery and procedural success rates. As infrastructure improves, more pet owners can pursue advanced musculoskeletal interventions, boosting demand for implants and prosthetics and facilitating market growth across both developed and emerging regions.
Regulatory & Ethical Challenges
Regulatory and ethical considerations pose challenges to the market. Strict compliance requirements, varying approval processes across regions and rigorous safety standards can delay product launches and increase operational costs. Ethical concerns surrounding surgical interventions, animal welfare, and prosthetic experimentation also influence market perception. Manufacturers must navigate complex legal frameworks while ensuring humane treatment, which can restrict innovation and adoption rates, particularly in regions with stringent veterinary regulations or heightened public scrutiny of animal medical procedures.
The Covid-19 pandemic temporarily disrupted the pet orthopedic market due to clinic closures, postponed surgeries, and limited supply chains. Elective procedures, including joint replacements and prosthetic fittings, were deferred, affecting revenue streams. However, the pandemic also accelerated pet ownership and increased attention to animal health, leading to heightened demand for orthopedic interventions post-lockdown. As clinics reopened, pent-up demand and technological adoption, such as teleconsultations for pre- and post-operative care, helped the market recover, reinforcing resilience and long-term growth prospects.
The prosthetics segment is expected to be the largest during the forecast period
The prosthetics segment is expected to account for the largest market share during the forecast period, due to rising demand for customized limb replacements. Advanced materials and precise engineering enable tailored solutions for pets with amputations or congenital deformities. Prosthetics restore mobility and improve quality of life, appealing to pet owners willing to invest in innovative solutions. Growing awareness of rehabilitation benefits, combined with technological advancements, ensures this segment maintains its market leadership, supported by veterinary expertise and increasing availability in clinics worldwide.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate as these facilities expand and adopt advanced orthopedic treatments. Clinics provide comprehensive services post-operative care, and prosthetic fittings, making them the preferred choice for pet owners. Investments in skilled personnel and rehabilitation programs drive higher adoption rates of implants and prosthetics. Increasing pet populations and urbanization contribute to clinic growth, positioning this segment as the fastest-growing channel for delivering specialized orthopedic care and innovative prosthetic solutions.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to increasing disposable income, and expanding veterinary infrastructure. Countries like China, Japan, and India are witnessing a growing trend of pet humanization, encouraging investment in advanced orthopedic treatments. The availability of modern clinics and skilled veterinary professionals further supports market expansion. Additionally, the region's growing awareness of pet health strengthens Asia Pacific's position as a dominant player in the global pet orthopedic implants and prosthetics market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to technological advancements in veterinary medicine. The region benefits from established veterinary infrastructure, widespread adoption of prosthetic solutions, and advanced surgical practices. Increasing focus on animal welfare and innovative treatment options fuels demand for orthopedic implants and prosthetics. Furthermore, robust research, development, and regulatory support facilitate rapid market growth, making North America a hotspot for new product introductions and cutting-edge orthopedic interventions in pets.
Key players in the market
Some of the key players in Pet Orthopedic Implants & Prosthetics Market include Orthomed UK, Veterinary Orthopedic Implants (VOI), BioMedtrix, IMEX Veterinary, Scil animal care, SECUROS Surgical, DePuy Synthes Vet, KYON, B.Braun Vet Care, Movora, K-9 Orthotics & Prosthetics, Arthrex Vet Systems, Bionic Pets, OrthoPets and Animal Ortho Care.
In July 2025, Movora and the AO Foundation signed a strategic collaboration to elevate global veterinary education, launching AO led surgical training events with Movora's support. This partnership aims to strengthen surgical skills, improve patient outcomes, and explore deeper cooperation in innovation and curriculum development.
In January 2022, Movora, the veterinary medtech arm of Vimian Group, has launched a U.S. presence with a new distribution center in St. Augustine, Florida, centralizing shipping for its BioMedtrix, KYON and Veterinary Orthopedic Implants brands and streamlining ordering, billing, education and support.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.